Prescribing Cultures and Pharmaceutical Policy in the Asia Pacific
by Eggleston, KarenFormat: Paperback
Pub. Date: 2009-09-17
Publisher(s): The Walter H. Shorenstein Asia-Pacific Research Center
Other versions by this Author
-
This Item Qualifies for Free Shipping!*
*Excludes marketplace orders.
List Price: $34.72
Rent Textbook
Select for Price
New Textbook
We're Sorry
Sold Out
Used Textbook
We're Sorry
Sold Out
eTextbook
We're Sorry
Not Available
How Marketplace Works:
- This item is offered by an independent seller and not shipped from our warehouse
- Item details like edition and cover design may differ from our description; see seller's comments before ordering.
- Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
- Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
- Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.
Summary
Pharmaceutical policies are interlinked globally and at the same time deeply rooted in local culture. Prescribing Cultures examines how pharmaceuticals and their regulation play an important and often contentions role in the health systems of the Asia-Pacific.
Author Biography
Karen Eggleston directs the Asia Health Policy Program at Shorenstein APARC. She is also a fellow at the Stanford Center for Health Policy. A former Fulbright scholar in South Korea, Eggleston has also studied in China and has served as a consultant to the World Bank on health service delivery in China.
Table of Contents
| Acknowledgments | p. ix |
| Foreword | p. xi |
| Introduction | p. 3 |
| Pharmaceutical Policy In Seven Asia-Pacific Health-Care Systems | |
| South Korea | |
| Pharmaceutical Policy in South Korea | p. 31 |
| Japan | |
| The Economics of Pharmaceutical Pricing and Physician Prescribing in Japan | p. 47 |
| The Political Economy of Incrementally Separating Prescription from Dispensation in Japan | p. 61 |
| Thailand | |
| Pharmaceutical Policy in Thailand: A Review of Three Decades of Government Interventions | p. 79 |
| Taiwan | |
| Pharmaceutical Policy in Taiwan | p. 109 |
| Australia | |
| Regulation and the Politics of Pharmaceuticals in Australia | p. 129 |
| The Australian Pharmaceutical Subsidy Gambit: Transmuting Deadweight Loss and Oligopoly Rents to Consumer Surplus | p. 145 |
| India | |
| The Evolution of Modern Indian Pharmaceuticals | p. 163 |
| China | |
| Pharmaceutical Policy and Health Reform in China | p. 179 |
| Streamlining China's Pharmaceutical Distribution Channels | p. 183 |
| Pharmaceutical Policy and the Appropriate Use of Medicines in China | p. 197 |
| Pharmaceutical Pricing in China | p. 205 |
| Challenges to China's Pharmaceutical Industry and Their Policy Implications | p. 223 |
| China's Underdeveloped Drug Regulation Regime: A Threat to Global Safety? | p. 235 |
| Cross-Cutting Themes | |
| Prescribing Cultures | |
| Ayurvedic Pharmaceutical Products: Government Policy, Marketing Rhetoric, and Rational Use | p. 251 |
| Physicians and Pharmacists in Comparative Historical Perspective: The Case of South Korea | p. 267 |
| Prescribing Patterns in Australia: Determinants and Implications for the Asia-Pacific | p. 281 |
| Access and Innovation | |
| Insurance Systems in the Asia-Pacific Region: Improving Appropriate Use of and Access to Medicines | p. 313 |
| Debating Drug Access and R&D Incentives | p. 337 |
| Encouraging Innovative Treatment for Neglected Diseases through Priority Review Vouchers | p. 347 |
| Conclusion: A Critical Review of the Dynamics and Regulation of Asian Pharmaceutical Industries | p. 367 |
| Index | p. 387 |
| About the Contributors | p. 415 |
| Table of Contents provided by Ingram. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.